TRAF3
TNF receptor-associated factor 3
Also known as: CAP-1, CD40bp, CRAF1, LAP1, RNF118, TRAF3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13114
- Gene
- TRAF3
- Ensembl
- ENSG00000131323
- Chromosome
- 14
- Canonical length
- 568 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from, members of the TNF receptor (TNFR) superfamily. This protein participates in the signal transduction of CD40, a TNFR family member important for the activation of the immune response. This protein is found to be a critical component of the lymphotoxin-beta receptor (LTbetaR) signaling complex, which induces NF-kappaB activation and cell death initiated by LTbeta ligation. Epstein-Barr virus encoded latent infection membrane protein-1 (LMP1) can interact with this and several other members of the TRAF family, which may be essential for the oncogenic effects of LMP1. The protein also plays a role in the regulation of antiviral response. Mutations in this are associated with Encephalopathy, acute, infection-induced, herpes-specific 5. [provided by RefSeq, Jul 2020]
Canonical amino-acid sequenceUniProt
568 residues, UniProt reviewed canonical sequence.
>Q13114|TRAF3
1 MESSKKMDSP GALQTNPPLK LHTDRSAGTP VFVPEQGGYK EKFVKTVEDK YKCEKCHLVL
61 CSPKQTECGH RFCESCMAAL LSSSSPKCTA CQESIVKDKV FKDNCCKREI LALQIYCRNE
121 SRGCAEQLML GHLLVHLKND CHFEELPCVR PDCKEKVLRK DLRDHVEKAC KYREATCSHC
181 KSQVPMIALQ KHEDTDCPCV VVSCPHKCSV QTLLRSELSA HLSECVNAPS TCSFKRYGCV
241 FQGTNQQIKA HEASSAVQHV NLLKEWSNSL EKKVSLLQNE SVEKNKSIQS LHNQICSFEI
301 EIERQKEMLR NNESKILHLQ RVIDSQAEKL KELDKEIRPF RQNWEEADSM KSSVESLQNR
361 VTELESVDKS AGQVARNTGL LESQLSRHDQ MLSVHDIRLA DMDLRFQVLE TASYNGVLIW
421 KIRDYKRRKQ EAVMGKTLSL YSQPFYTGYF GYKMCARVYL NGDGMGKGTH LSLFFVIMRG
481 EYDALLPWPF KQKVTLMLMD QGSSRRHLGD AFKPDPNSSS FKKPTGEMNI ASGCPVFVAQ
541 TVLENGTYIK DDTIFIKVIV DTSDLPDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 18 nTPM
- lymph node: 17 nTPM
- appendix: 15 nTPM
- cerebral cortex: 12 nTPM
- tonsil: 12 nTPM
- hippocampal formation: 12 nTPM
Single-cell type
- neutrophils: 582 nCPM
- plasma cells: 528 nCPM
- b-cells: 397 nCPM
- monocytes: 323 nCPM
- neutrophil progenitors: 312 nCPM
- pdcs: 284 nCPM
Immune cell
- memory B-cell: 9.6 nTPM
- naive B-cell: 9.6 nTPM
- plasmacytoid DC: 5.1 nTPM
- classical monocyte: 4.7 nTPM
- memory CD4 T-cell: 3.9 nTPM
- total PBMC: 3.9 nTPM
Brain region
- hippocampal formation: 42 nTPM
- cerebral cortex: 39 nTPM
- hypothalamus: 35 nTPM
- midbrain: 31 nTPM
- medulla oblongata: 30 nTPM
- pons: 30 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRAF3.
Disease | AllUniProt
Conditions TRAF3 is implicated in, by any mechanism.
- Immunodeficiency 132A (IMD132A) MIM:614849
- Immunodeficiency 132B (IMD132B) MIM:621096
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 457 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 132b
- TRAF3 haploinsufficiency
- Herpes simplex encephalitis, susceptibility to, 3
- TRAF3-related disorder
- Autosomal dominant TRAF3-related disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.99
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell surface receptor signaling pathway
- defense response to virus
- negative regulation of NF-kappaB transcription factor activity
- positive regulation of type I interferon production
- regulation of apoptotic process
- regulation of canonical NF-kappaB signal transduction
- regulation of cytokine production
- regulation of defense response to virus
- regulation of interferon-beta production
- regulation of proteolysis
- signal transduction
- Toll signaling pathway
- toll-like receptor 4 signaling pathway
- toll-like receptor signaling pathway
- TRIF-dependent toll-like receptor signaling pathway
- tumor necrosis factor-mediated signaling pathway
- type I interferon-mediated signaling pathway
Molecular functions
- identical protein binding
- protein kinase binding
- protein phosphatase binding
- signaling adaptor activity
- thioesterase binding
- tumor necrosis factor receptor binding
- ubiquitin protein ligase activity
- ubiquitin protein ligase binding
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, TRAF-type
- Zinc finger, RING-type
- MATH/TRAF domain
- TRAF-like
- TNF receptor-associated factor TRAF, metazoa
- Zinc finger, RING/FYVE/PHD-type
- Zinc finger, RING-type, conserved site
- TRAF1-6, MATH domain
- TNF receptor-associated factor 3/5, RING domain
- TRAF-type zinc finger
- TRAF/meprin, MATH domain
- TNF receptor-associated factor 2/3/5, RING domain
- TNF receptor-associated factor 3, C3HC3D-type RING zinc finger
- TNF receptor-associated factor 3, MATH domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAF3 as an antibody target. Whether an autoantibody or antibody against TRAF3 could matter depends on whether native TRAF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRAF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...